|
Major Depressive Disorder (MDD) - Market Insights, Epidemiology and Market Forecast-2027 |
Dec 5 2018 |
100 |
Global |
$6,250.00 |
|
|
Lipodystrophy Syndrome (LS)- Market Insights, Epidemiology and Market Forecast-2027 |
Dec 5 2018 |
100 |
Global |
$6,250.00 |
|
|
Attention Deficit Hyperactivity Disorder (ADHD) - Market Insights, Epidemiology and Market Forecast-2027 |
Dec 5 2018 |
100 |
Global |
$6,250.00 |
|
|
Cutaneous Squamous Cell Carcinoma (cSCC) - Market Insights, Epidemiology and Market Forecast-2027 |
Dec 5 2018 |
100 |
Global |
$6,250.00 |
|
|
Autism Spectrum Disorder (ASD) - Market Insights, Epidemiology and Market Forecast-2027 |
Dec 5 2018 |
157 |
Global |
$6,250.00 |
|
|
Multiple Sclerosis (MS) - Market Insights, Epidemiology and Market Forecast-2027 |
Dec 5 2018 |
100 |
Global |
$6,250.00 |
|
|
Lyme disease (LD)- Market Insights, Epidemiology and Market Forecast-2027 |
Dec 5 2018 |
163 |
Global |
$6,250.00 |
|
|
Limb Girdle Muscular Dystrophy (LGMD)-Market Insights, Epidemiology and Market Forecast-2027 |
Dec 5 2018 |
100 |
Global |
$6,250.00 |
|
|
Charcot Marie Tooth (CMT) - Market Insights, Epidemiology and Market Forecast-2027 |
Dec 5 2018 |
100 |
Global |
$6,250.00 |
|
|
Peripheral T-Cell Lymphoma (PTCL) - Market Insights, Epidemiology and Market Forecast-2027 |
Dec 5 2018 |
100 |
Global |
$6,250.00 |
|
|
Global Allergy Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Leukemia Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Neuropathy Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Asthma Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Cardiovascular Partnering 2012-2018: Deal trends, players and financials |
Sep 1 2018 |
500 |
Global |
$2,995.00 |
|
|
Global Ulcerative Colitis Partnering 2012-2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Musculoskeletal Partnering 2012-2018: Deal trends, players and financials |
Sep 1 2018 |
1000 |
Global |
$2,995.00 |
|
|
Global Human Papilloma Virus Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Hypertension Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Age-related Macular Degeneration Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Cancer Vaccine Partnering 2012-2018: Deal trends, players, financials and forecasts |
Sep 1 2018 |
200 |
Global |
$2,995.00 |
|
|
Global Systemic Lupus Erythematosus Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Gastric Cancer Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Parkinson's Disease Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Smoking Cessation Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Autoimmune Partnering 2012-2018: Deal trends, players and financials |
Sep 1 2018 |
700 |
Global |
$2,995.00 |
|
|
Global Esophageal Reflux Partnering 2012-2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Viral Partnering 2012-2018: Deal trends, players and financials |
Sep 1 2018 |
500 |
Global |
$2,995.00 |
|
|
Global Clostridium difficile Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Non-Hodgkin Lymphoma Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
